Loading
Latest filing published 09 Sept 2026 for Barinthus Biotherapeutics plc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Alex Hammacher (board member) discloses dealings in Vaccitech plc to SEC (Form 4). In total, 3 filings cover trades dated from 31 December 2021 to 9 September 2026.
No open-market sale appears; the market trades are 2 purchases worth €19k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 9 September 2026, reports a transaction in Vaccitech plc. The last purchase on record was published on 4 April 2022, which is 1,662 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations